Cargando…
Differential Expression and Pathway Analysis in Drug-Resistant Triple-Negative Breast Cancer Cell Lines Using RNASeq Analysis
Triple-negative breast cancer (TNBC) is among the most notorious types of breast cancer, the treatment of which does not give consistent results due to the absence of the three receptors (estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) as well...
Autores principales: | Shaheen, Safa, Fawaz, Febin, Shah, Shaheen, Büsselberg, Dietrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032108/ https://www.ncbi.nlm.nih.gov/pubmed/29921827 http://dx.doi.org/10.3390/ijms19061810 |
Ejemplares similares
-
The “Yin and Yang” of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
por: Varghese, Elizabeth, et al.
Publicado: (2018) -
High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells
por: Varghese, Sharon, et al.
Publicado: (2019) -
Integrated analysis of differentially expressed genes and pathways in triple-negative breast cancer
por: Peng, Cancan, et al.
Publicado: (2017) -
Triptolide Decreases Cell Proliferation and Induces Cell Death in Triple Negative MDA-MB-231 Breast Cancer Cells
por: Varghese, Elizabeth, et al.
Publicado: (2018) -
Differential expression analysis for RNAseq using Poisson mixed models
por: Sun, Shiquan, et al.
Publicado: (2017)